Dr. R. Squitti’s research focuses on metal involvement in metabolic, neurological, and psychiatric illnesses. She was the first to discover that the fraction of serum copper not bound to ceruloplasmin, referred to Non-Ceruloplasmin copper (or ‘free’ or ‘labile’ copper; two patents) is a risk factor for Alzheimer’s disease (Squitti et al, Neurol 2002, 2003, 2005, 2006, 2009; Squitti et al Ann Neurol 2014; Squitti et al Biomolecules 2021), and that the ATP7B - the gene that controls copper excretion and whose mutations cause Wilson's disease - is also a susceptibility gene for Alzheimer's disease (Squitti et al, J Alzheimer’s Dis. 2021; Squitti et al, Metallomics 2016). She is a World's top 2% scientists (https://doi.org/10.17632/btchxktzyw.1) and the author of more than 140 peer-reviewed papers, ORCID (http://orcid.org/0000-0002-5624-1140, whose citations you can track at Rosanna Squitti Google Scholar – H index 49 Rosanna Squitti Scopus – H index 43, citations (Google Scholar) 7038